Professional Documents
Culture Documents
From: Next Generation Drugs. Source: Authors research & analysisIncreasing Competition
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
The impact of bioinformatics on drug discovery productivity
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Key enabling technologies driving pharmaceutical innovation
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Drug-response genes
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Genomics-driven companies with respective technology platforms
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Importance of key enabling technologies, 1999-2005
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Change in perceived relative importance of drug discovery
technologies, 1999-2005
From: Next Generation Drugs. Source: Authors research & analysis, Datamonitor
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Companies using pharmacogenomic studies in drug development
From: Next Generation Drugs. Source: Reuters Business Insight Pharmacogenomics Survey, 2000
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2002
Benefits of genetic profiling in R&D